Argentina vs Malta: Access to anti-retroviral drugs, male
Argentina
74.0%
in 2024
Malta
74.0%
in 2024
Argentina rank
58th
Malta rank
58th
Access to anti-retroviral drugs, male over time
- Argentina
- Malta
How they compare
Argentina currently reports 74.0% against 74.0% in Malta, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Malta ahead.
Argentina ranks 58th and Malta ranks 58th of 141 countries.
Argentina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.5% | 21.6% | 7.9% | Argentina |
| 2010s | 56.3% | 45.0% | 11.3% | Argentina |
| 2020s | 71.6% | 65.4% | 6.2% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Argentina or Malta?
- Argentina, at 74.0% against 74.0% in Malta as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Argentina and Malta?
- 0.0%, with Argentina ahead.
- How many years of comparable data are there for Argentina and Malta?
- 25 years are reported by both, from 2000 to 2024.
- How do Argentina and Malta rank globally for access to anti-retroviral drugs, male?
- Argentina ranks 58th and Malta ranks 58th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.